A 54-year-old woman with a diagnosis of Erdheim-Chester disease under therapy with dabrafenib presents with clinical signs of heart failure. After discontinuing the offending medication and initiating guideline-directed medical therapy for heart failure with reduced ejection fraction, the clinical picture improved.
Keywords: Erdheim-Chester disease; aortitis; cardiorenal syndrome; dabrafenib; heart failure with reduced ejection fraction.
© 2024 The Authors.